Início
Mercados
Gráficos e ideias
Algo
Notícias
Market
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Heatmap
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
XENE
#1341
Xenon Pharmaceuticals Inc
58.880
0
USD
-0.79%
Setor:
Cuidados de saúde
Base:
USD
Moeda do lucro:
USD
Faixa diária
Faixa anual
Mudança diária
-0.79%
Mudança mensal
+6.94%
Mudança em 6 meses
+44.35%
Mudança anual
+44.35%
Fechamento anterior
59.350
0
Abrir
58.880
0
Bid
Ask
Mínimo
58.880
0
High
58.880
0
Volume
62
Mercados
Ações
Cuidados de saúde
XENE
Abrir gráfico completo
Financials
Visão geral
Relatórios
Estatísticas
Trimestral
Ano
Valor
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
76.54 M
76.73 M
77.11 M
77.28 M
83.19 M
—
Valuation ratios
Enterprise value
2.86 B
2.46 B
2.28 B
3 B
3.53 B
11.26 B
Price to earnings ratio
-13.02
-10.42
-8.84
-10.35
-10.28
-39.89
Price to sales ratio
-2 869.8
421.96
394.3
525.94
473.62
1 815.83
Price to cash flow ratio
-16.83
-13.41
-10.67
-12.54
-12.73
-49.36
Price to book ratio
4.04
0.84
0.85
1.19
6.11
8.99
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.08
-0.09
-0.13
-0.15
-0.17
-0.53
Return on equity %
-0.09
-0.09
-0.13
-0.16
-0.18
-0.57
Return on invested capital %
-171.26
-170.59
-211.02
-254.85
-434.29
-1 070.74
Gross margin %
100
100
—
—
—
—
Operating margin %
5 242.02
-969.84
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
4 444.18
-867.29
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
17.85
17.66
15.14
12.52
13.42
58.73
Inventory turnover
—
—
—
—
—
—
Asset turnover
-0
0.01
0
0
0
0.01
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.7
-0.78
-0.81
-0.91
-1.03
-3.53
EBIT per share
-1.01
-0.92
-1.19
-1.22
-1.39
-4.72
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
8.05
6.98
6.18
5.83
6.93
25.92
Net current asset value per share
8.16
7.19
6.34
6.06
7.07
26.66
Tangible book value per share
9.69
8.95
8.03
7.06
7.34
31.38
Working capital per share
7.7
6.78
5.92
5.57
6.55
24.82
Book value per share
9.69
8.95
8.03
7.06
7.34
31.38
Notícias
Xenon Pharmaceuticals apresentará dados de azetukalner para epilepsia na AAN
Xenon Pharmaceuticals Stock Soars 20% in 3 Months: Here's Why
Wedbush reduz preço-alvo das ações da Xenon Pharmaceuticals para US$ 63
Wedbush lowers Xenon Pharmaceuticals stock price target to $63
BofA eleva preço-alvo da Xenon Pharmaceuticals após sucesso em estudo
BofA raises Xenon Pharmaceuticals price target on trial success
Xenon Pharmaceuticals conclui oferta pública de US$ 747,5 milhões
Xenon Pharmaceuticals closes $747.5M public offering
Xenon Pharmaceuticals precifica oferta pública de US$ 650 milhões a US$ 57 por ação
Xenon Pharmaceuticals prices $650M public offering at $57/share
XENE Stock Up as Azetukalner Meets Goal in Focal Onset Seizures Study
Citizens reiterates Rapport Therapeutics stock rating on seizure drug potential